Functional screening method involving protein translocation/redistribution

Details for Australian Patent Application No. 2003254442 (hide)

Owner GE Healthcare UK Limited

Inventors Thomas, Nicholas; O'Beirne, Gerard

Agent Davies Collison Cave

Pub. Number AU-B-2003254442

PCT Number PCT/GB03/02983

PCT Pub. Number WO2004/009847

Priority 0216674.2 18.07.02 GB

Filing date 10 July 2003

Wipo publication date 9 February 2004

Acceptance publication date 2 November 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 0216674.2 18.07.02 GB

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003254442

23 March 2006 Change of Name(s) of Applicant(s), Section 104

  Amersham Bio-Sciences UK Limited The name of the applicant has been changed to GE Healthcare UK Limited

2 November 2006 Application Accepted

  Published as AU-B-2003254442

8 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003254443-Modified soluble T cell receptor

2003254441-SULPHONYLPIPERIDINE DERIVATIVES CONTAINING AN ARYL OR HETEROARYL GROUP FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS